Busulfan Injection, Solution, Concentrate
Product Images NDC 25021-241

2 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Busulfan (NDC 25021-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bus02 0006 01)

Chemical Structure (Bus02 0006 01)
Chemical structure diagram of busulfan, showing its molecular configuration with two methanesulfonate groups connected by a butane chain, consistent with the active ingredient busulfan.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Bus02 0006 02)

Package Label – Principal Display Panel – Vial Label (Bus02 0006 02)
Label for Busulfan Injection 60 mg per 10 mL (6 mg per mL) solution concentrate for intravenous use, produced by Sagent Pharmaceuticals. The label indicates a 10 mL single-dose vial, with warnings to discard unused portions and notes that it is a cytotoxic agent requiring dilution before use. The label also includes storage instructions and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.